Navigation Links
Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis
Date:6/17/2008

STUDY TO ASSESS IMPACT OF ELAGOLIX ON BONE MINERAL DENSITY

SAN DIEGO, June 17 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the elagolix 0603 Phase IIb trial (Petal Study) has completed the 6-month treatment phase. The last subject completed her Week 24 study visit in early June. This Phase IIb trial assesses the impact of elagolix treatment on bone mineral density (BMD) as the primary endpoint using Dual Energy X-ray Absorptiometry (DXA) scans to document any change from baseline. In addition, efficacy assessments of endometriosis symptoms using the Composite Pelvic Sign and Symptoms Score (CPSSS) and Visual Analog Scale (VAS) are secondary endpoints.

"The Petal Study is an important trial for the elagolix program," says Christopher O'Brien, MD, Chief Medical Officer and Senior Vice President of Clinical Development. "For the first time we have the opportunity to examine the relationship between estradiol, n-telopeptide (a biomarker for bone resorption), elagolix plasma concentrations and BMD using DXA. We included a positive control, Depo-Provera, as one treatment arm in this randomized, double-blind, active comparator controlled trial to provide confidence that the trial would not miss subtle treatment-related effects," stated Dr. O'Brien.

"The recruitment process for the Petal Study confirms that endometriosis is an important, unmet medical need afflicting many women in the United States. Our call center received over 8,000 calls expressing interest in new treatments for endometriosis," reports Dr. O'Brien. A total of 252 women with endometriosis were randomized to one of three treatment arms: oral elagolix 150mg once daily, oral elagolix 75mg twice daily or Depo-P
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Neurocrine Biosciences Reports First Quarter 2008 Results
2. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
3. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
4. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
5. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
6. Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743
7. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
8. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
9. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
10. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
11. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... 2013 Although colonoscopy exams prevent many colon ... sensitive method for detecting colorectal cancers 2 , the ... 3 . EndoChoice ® Inc. today unveiled research ... the accuracy of this procedure and greatly reduces the ... discussing these clinical trial results and featuring the Fuse ...
(Date:5/17/2013)... , May 17, 2013 Medical devices are ... a biological product. In light of their different mechanisms, ... are much more complicated than drug trails due to ... MD safety instead of evaluating both safety and efficacy ... FDA (which is the same as the SFDA) evaluate ...
(Date:5/17/2013)... 2013  Technology advances have had a profound ... a constantly evolving communication environment, companies need to ... with internal executives. It is challenging, however, to ... and tools that are part of today,s communication ... Best Practices, LLC explores the various internal communication ...
Breaking Medicine Technology:New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 2New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 3Statistical Challenges in Medical Device Trail Evaluation 2Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2
... Sept. 20, 2011 Misonix, Inc. (NASDAQ: ... designs, manufactures and markets innovative therapeutic ultrasonic products ... surgery, and other surgical and medical applications, today ... and year ended June 30, 2011.  Michael A. ...
... Johnson & Johnson (NYSE: JNJ ) today announced ... comprehensive effort designed to improve the health of as many ... countries by 2015. Since its launch last ... measurable impact in several areas toward Every Woman, Every ...
Cached Medicine Technology:Misonix Reports Fourth Quarter and Year-End Fiscal 2011 Financial Results 2Misonix Reports Fourth Quarter and Year-End Fiscal 2011 Financial Results 3Misonix Reports Fourth Quarter and Year-End Fiscal 2011 Financial Results 4Misonix Reports Fourth Quarter and Year-End Fiscal 2011 Financial Results 5Misonix Reports Fourth Quarter and Year-End Fiscal 2011 Financial Results 6Misonix Reports Fourth Quarter and Year-End Fiscal 2011 Financial Results 7Misonix Reports Fourth Quarter and Year-End Fiscal 2011 Financial Results 8Johnson & Johnson Makes Strong Progress in First Year of Initiative to Improve Health of Millions of Women and Children in the Developing World 2Johnson & Johnson Makes Strong Progress in First Year of Initiative to Improve Health of Millions of Women and Children in the Developing World 3Johnson & Johnson Makes Strong Progress in First Year of Initiative to Improve Health of Millions of Women and Children in the Developing World 4Johnson & Johnson Makes Strong Progress in First Year of Initiative to Improve Health of Millions of Women and Children in the Developing World 5Johnson & Johnson Makes Strong Progress in First Year of Initiative to Improve Health of Millions of Women and Children in the Developing World 6
(Date:5/19/2013)... May 19, 2013 Actos lawsuit ... litigation now underway in U.S. District Court, Western District ... dated May 3rd, the Court has modified the litigation’s ... eight cases rather than four. The next Status Conference ... May 23rd. (In re: Actos Product Liability Litigation, MDL ...
(Date:5/19/2013)... According to a new market ... (2013 – 2018): By Applications (Healthcare (Endoscopy, Radiology, ... CMOS, Contact IS, Infrared, X-Ray) And Geography" published ... was $8.00 billion in 2012 and is expected ... estimated CAGR of 3.84% from 2013 to 2018. ...
(Date:5/19/2013)... 19, 2013 Fat Burning Furnace developed ... that provides people with fat burning diet ... this Fat Burning Furnace package, people will receive the ... can download quickly. The Fat Burning Furnace manual includes ... build lean muscle mass. In addition, this book covers ...
(Date:5/19/2013)... Dr. Keith Chertok now provides gum disease patients with a ... the chance of a healthier smile. Laser gum surgery ... only removes diseased gum tissue in patients, but it also ... dental implants. , LANAP uses a laser to successfully ... stimulate the healthy tissue as well as encourage new bone ...
(Date:5/19/2013)... Agora Health Limited developed by Rachael Linkie is a new ... increase memory power naturally and effectively. The program also ... their entire health from the inside out. It also helps ... mind. In addition, the program helps people keep their memory ... claimed that this program can help people overcome a family ...
Breaking Medicine News(10 mins):Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2Health News:Berkeley, CA Periodontist, Dr. Keith Chertok Now Treats Gum Disease Patients With Laser Gum Surgery Prior to Placing Dental Implants 2Health News:How To Increase Memory Power | How “Agora Health Limited” Helps People Improve Their Memory Naturally And Effectively – Health Review 2
... RICHMOND, Calif., Aug. 26 Transcept Pharmaceuticals, Inc. (Nasdaq: ... conferences. , , , Rodman & ... EDT. , Baird 2009 Health Care Conference on Thursday, ... , , A live audio webcast ...
... , SAN MARINO, Calif., Aug. 26 ... drug compounds for HIV/AIDS, autoimmune diseases, and cancer, has completed its ... of approximately 36 million additional shares of common stock in exchange ... , According to Viral Genetics, CEO Haig Keledjian, "We ...
... , , WASHINGTON, Aug. 26 ... the National Association of Psychiatric Health Systems: , , ... Psychiatric Health Systems (NAPHS), I would like to express deepest sympathies to ... , Sen. Kennedy was a staunch and unwavering supporter of ...
... , WASHINGTON, Aug. 26 Loretta King, ... Division, announced today that a federal grand jury in Denver ... commerce and with violating the Freedom of Access to Clinic ... Colorado abortion clinic. The FACE Act makes it a federal ...
... , , WASHINGTON, Aug. 26 ... health community in mourning the loss of Senator Edward M. Kennedy, ... the medically underserved. His work in advancing medical innovation has left ... to invest in cures for illnesses that affect patients around the ...
... Aug. 26 (HealthDay News) -- Two new European reports should ... diagnosing possible heart attacks in emergency room patients, cardiologists say. ... of the New England Journal of Medicine , looked ... cells. Standard practice in most hospitals now calls for a ...
Cached Medicine News:Health News:Transcept Pharmaceuticals to Present at Rodman & Renshaw and Baird Healthcare Investor Conferences on September 9 and September 10, 2009 2Health News:Transcept Pharmaceuticals to Present at Rodman & Renshaw and Baird Healthcare Investor Conferences on September 9 and September 10, 2009 3Health News:Viral Genetics Completes Second Major Debt Conversion 2Health News:Viral Genetics Completes Second Major Debt Conversion 3Health News:Council for American Medical Innovation Honors Health Champion Senator Edward M. Kennedy 2Health News:Council for American Medical Innovation Honors Health Champion Senator Edward M. Kennedy 3Health News:Newer, Better Tests for Heart Attacks 2Health News:Newer, Better Tests for Heart Attacks 3
... Practice management software for ... a true multi-tasking, multi-office practice ... in database technology- Winx Pro ... will assist you in effectively ...
... over 2,500 ophthalmologists nationwide, ... serve one of the ... in the country. With ... we are setting new ...
... Intuition EMR Ophthalmology is a comprehensive ... tailored for ophthalmology practices. Intuition EMR ... but provides the tools to evaluate ... you to make better decisions and ...
... the latest in advanced cartridge mixing and ... mixes and mechanically injects all types of ... ,The Revolution&trade line-up includes a large selection ... even in difficult to access areas. A ...
Medicine Products: